Novel RNA Interference (RNAi)-Based Nanomedicines for Treating Viral Infections - Harnessing Biomaterials in Nanomedicine: Preparation, Toxicity, and Applications - page 227

References
1. Alvarez, R., Elbashir, S., Borland, T., Toudjarska, I., Hadwiger, P., John, M.,
Roehl, I., Morskaya, S. S., Martinello, R., Kahn, J., Van Ranst, M., Tripp,
R. A., DeVincenzo, J. P., Pandey, R., Maier, M., Nechev, L., Manoharan,
M., Kotelianski, V. and Meyers, R. (2009). RNA interference-mediated
silencing of the respiratory syncytial virus nucleocapsid defines a
potent antiviral strategy. Antimicrob Agents Chemother, 53, pp. 3952-
3962.
2. An, D. S., Donahue, R. E., Kamata, M., Poon, B., Metzger, M., Mao, S. H.,
Bonifacino, A., Krouse, A. E., Darlix, J. L., Baltimore, D., Qin, F. X. and Chen,
I. S. (2007). Stable reduction of CCR5 by RNAi through hematopoietic
stem cell transplant in non-human primates. Proc Natl Acad Sci U S A,
104, pp. 13110-13115.
3. Anderson, J., Li, M. J., Palmer, B., Remling, L., Li, S., Yam, P., Yee, J. K.,
Rossi, J., Zaia, J. and Akkina, R. (2007). Safety and efficacy of a lentiviral
vector containing three anti-HIV genes — CCR5 ribozyme, tat-rev
siRNA, and TAR decoy — in SCID-hu mouse-derived T cells. Mol Ther,
15, pp. 1182-1188.
4. Anderson, J. S., Walker, J., Nolta, J. A. and Bauer, G. (2009). Specific
transduction of HIV-susceptible cells for CCR5 knockdown and
resistance to HIV infection: a novel method for targeted gene therapy
and intracellular immunization. J Acquir Immune Defic Syndr, 52, pp.
152-161.
5. Bai, F., Wang, T., Pal, U., Bao, F., Gould, L. H. and Fikrig, E. (2005). Use of
RNA interference to prevent lethal murine West Nile virus infection. J
Infect Dis, 191, pp. 1148-1154.
6. Banerjea, A., Li, M. J., Bauer, G., Remling, L., Lee, N. S., Rossi, J. and
Akkina, R. (2003). Inhibition of HIV-1 by lentiviral vector-transduced
siRNAs in T lymphocytes diff erentiated in SCID-hu mice and CD34+
progenitor cell-derived macrophages. Mol Ther, 8, pp. 62-71.
7. Barnett, E. D. (2007). Yellow Fever: Epidemiology and Prevention. Clin
Infect Dis, 44, pp. 850-856.
8. Bennasser, Y., Le, S. Y., Benkirane, M. and Jeang, K. T. (2005). Evidence
that HIV-1 encodes an siRNA and a suppressor of RNA silencing.
Immunity, 22, pp. 607-619.
9. Bitko, V. and Barik, S. (2001). Phenotypic silencing of cytoplasmic
genes using sequence-specific double-stranded short interfering RNA
and its application in the reverse genetics of wild type negative-strand
RNA viruses. BMC Microbiol, 1, p. 34.
10. Bitko, V. and Barik, S. (2008). Nasal delivery of siRNA. Methods Mol
Biol, 442, pp. 75-82.